Publicacións en colaboración con investigadores/as de Pierre and Marie Curie University (20)

2024

  1. Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip), Pisa, Italy, 28–29 September 2023

    Annales d'Endocrinologie

  2. Serotonergic underpinnings of obsessive-compulsive disorder: A systematic review and meta-analysis of neuroimaging findings

    Psychiatry and Clinical Neurosciences

2022

  1. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up

    European Heart Journal, Vol. 43, Núm. 11, pp. 1059-1103

  2. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis

    European Heart Journal, Vol. 43, Núm. 11, pp. 1033-1058

  3. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis

    Cardiovascular research, Vol. 118, Núm. 6, pp. 1385-1412

  4. One-Year Major Cardiovascular Events After Restrictive Versus Liberal Blood Transfusion Strategy in Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Trial

    Circulation

  5. Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip) Cambridge, UK, 7–8 April 2022

    Annales d'Endocrinologie

  6. Stress response in dissociation and conversion disorders: A systematic review

    Neuroscience and Biobehavioral Reviews, Vol. 132, pp. 957-967

2021

  1. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 3, pp. 1020-1030.e10

  2. Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events among Patients with Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial

    JAMA - Journal of the American Medical Association, Vol. 325, Núm. 6, pp. 552-560

  3. Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 4, pp. 1041-1052

  4. Secukinumab in patients with psoriatic arthritis and axial manifestations: Results from the double-blind, randomised, phase 3 MAXIMISE trial

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 5, pp. 582-590

  5. Worsening of chronic house-dust-mite-induced respiratory allergies: An observational survey in three European countries

    World Allergy Organization Journal, Vol. 14, Núm. 7

2020

  1. The disease burden in patients with respiratory allergies induced by house dust mites: a year-long observational survey in three European countries

    Clinical and Translational Allergy, Vol. 10, Núm. 1

2017

  1. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 72, Núm. 3, pp. 462-472

2016

  1. "A year-long, fortnightly, observational survey in three European countries of patients with respiratory allergies induced by house dust mites: Methodology, demographics and clinical characteristics"

    BMC Pulmonary Medicine, Vol. 16, Núm. 1

  2. Clinical utility gene card for: Congenital generalized lipodystrophy

    European Journal of Human Genetics, Vol. 24, Núm. 11

  3. Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: Results from the MAGGIC individual patient data meta-analysis

    QJM, Vol. 109, Núm. 6, pp. 377-382

2014

  1. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

2013

  1. Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: Analysis from the SHIFT study

    Clinical Research in Cardiology, Vol. 102, Núm. 1, pp. 11-22